Cronos Logo
CA22717L1013
A2DMQY
CRON

Cronos

Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è +2,70 (11,48%). La mediana è +2,49 (18,36%).

Acquista
  3
Mantieni
  9
Vendi
  3

  • Cronos Group hits 52-week high after strong Q2 results

    The Cronos Group share rose to a 52-week high of $3.44, with a market capitalization of $1.25 billion and year-to-date performance of 25.86%. InvestingPro points to an overvaluation versus fair value. Cronos beat expectations in Q2 2026 with revenue of $53 million (expectation $44.73 million), adjusted EPS of $0.09 (expectation $0.01), gross profit of $28.5 million and adjusted EBITDA of $13.1 million; cash and investments amounted to $827 million, and $60 million in share buybacks were reported. » Altro su de.investing.com


  • Cronos shares rise after Q2 results significantly beat expectations

    Cronos reported Q2 EPS of $0.09 (consensus $0.01) and revenue of $53.0 million versus expected $44.73 million. The company reported record net revenue, gross profit and adjusted EBITDA, organic revenue growth of 51% and record sales in Israel, Canada and Germany. Cronos repurchased a total of 12.3 million shares in H1 2026. The strong company-specific metrics pushed the stock sharply higher in pre-market trading and brought it closer to its 52-week high. » Altro su de.investing.com


  • Cronos Group names ATB Capital Markets as broker for share buyback program

    Cronos Group has appointed ATB Capital Markets Corp. (ATB Cormark) as broker for share repurchases on the Toronto Stock Exchange and other Canadian trading systems, replacing Virtu Canada Corp. The company gave no details on the reasons, size or timing of the buyback program. Cronos has most recently pursued an aggressive buyback strategy, which coincided with a 49% share price increase last year; market capitalization is around USD 1.04 billion. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, Cronos ha registrato ricavi pari a +61,86M e un utile netto di +28,11M
(EUR) giu 2026
YoY
Ricavi +61,86M 117,93%
Utile lordo +24,93M 102,58%
Utile netto +28,11M 183,44%
EBITDA +31,63M 10.629,72%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
+1,14Md
Numero di azioni
373,66M
Massimo/minimo a 52 settimane
+3,07 - +1,96
Dividendi No
Beta
1,24
Rapporto P/E
+18,99
Rapporto PEG
0,00
Rapporto P/B
+1,25
Rapporto P/S
+7,44

Profilo aziendale

Die Cronos Group Inc. ist als Cannabinoid-Unternehmen tätig. Es produziert, vermarktet und vertreibt aus Hanf gewonnene Nahrungsergänzungsmittel und kosmetische Produkte über E-Commerce-, Einzelhandels- und Gaststättenpartnerkanäle unter den Marken Lord Jones und Happy Dance in den Vereinigten Staaten. Das Unternehmen befasst sich auch mit dem Anbau, der Herstellung und der Vermarktung von Cannabis und Cannabisprodukten für den medizinischen Markt und den Markt für den Gebrauch durch Erwachsene. Es verkauft Cannabis und Cannabisprodukte, darunter getrocknetes Cannabis, Pre-Rolls, Esswaren, Konzentrate und Cannabisextrakte über Großhandels- und Direktvertriebskanäle unter seiner Wellness-Plattform PEACE NATURALS und ist unter der Marke Spinach für den Gebrauch durch Erwachsene tätig. Das Unternehmen exportiert auch getrocknetes Cannabis und Cannabisöle nach Deutschland, Israel und Australien. Die Cronos Group Inc. wurde im Jahr 2012 gegründet und hat ihren Sitz in Toronto, Kanada.

Nome
Cronos
CEO
Michael Ryan Gorenstein
Sede centrale Stayner, on
Canada
Sito web
Settore
Sanità
Industria
Fornitori e servizi sanitari
Quotazione in borsa
27/02/2018
Dipendenti 610

Simboli di borsa

Borsa Simbolo
NASDAQ
CRON
Toronto Stock Exchange
CRON.TO
Frankfurt
7CI.F
Düsseldorf
7CI.DU
München
7CI.MU
🍪

Parqet  usa i cookie. Scopri di più